Singapore Clinical Research Institute (SCRI)
↗Singapore, Singapore
The Singapore Clinical Research Institute (SCRI) is a national clinical research organization in Singapore. It serves as the National Coordinating Body for clinical trials, aiming to enhance the quality and efficiency of clinical research in the country by providing support for study design, protocol development, regulatory compliance, and trial management.
SCRI is a business unit under the Consortium for Clinical Research and Innovation Singapore (CRIS), which is a wholly owned subsidiary of MOH Holdings (the holding company for Singapore's public healthcare clusters). SCRI works closely with public healthcare institutions, academic centers, and industry partners to facilitate both investigator-initiated and industry-sponsored clinical trials.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Clinical Research Organization / Academic Research Organization
SIZE & FINANCIALS
Ownership:government
Status:operating
CORPORATE STRUCTURE
Parent Company:Consortium for Clinical Research and Innovation Singapore (CRIS)
Key Partnerships:Oncoshot (Feasibility assessment platform), Health Sciences Authority (HSA), National University Health System (NUHS), SingHealth
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Danny Soon - Chief Executive Officer
LINKS
Website:scri.cris
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Singapore Clinical Research Institute (SCRI) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Singapore Clinical Research Institute (SCRI). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.